Decitabine Maintains Hematopoietic Precursor Self-Renewal by Preventing Repression of Stem Cell Genes by a Differentiation-Inducing Stimulus
暂无分享,去创建一个
J. Maciejewski | Harinder Singh | Y. Saunthararajah | R. Mahfouz | Q. Ebrahem | X. Gu | E. Copelan | Zhenbo Hu | S. Negrotto | K. Ng
[1] K. Akashi,et al. [Myeloid lineage commitment from the hematopoietic stem cell]. , 2007, Arerugi = [Allergy].
[2] Suman Lee,et al. Undifferentiated hematopoietic cells are characterized by a genome-wide undermethylation dip around the transcription start site and a hierarchical epigenetic plasticity. , 2009, Blood.
[3] R. Jaenisch,et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction , 2009, Nature Genetics.
[4] S. Orkin,et al. DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells. , 2009, Cell stem cell.
[5] C. Perry,et al. Chemical decomposition of 5-aza-2'-deoxycytidine (Decitabine): kinetic analyses and identification of products by NMR, HPLC, and mass spectrometry. , 2009, Chemical research in toxicology.
[6] Daniel Nowak,et al. Differentiation therapy of leukemia: 3 decades of development. , 2009, Blood.
[7] E. Li,et al. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation , 2009, Nature Genetics.
[8] Y. Saunthararajah,et al. Clinical effectiveness of decitabine in severe sickle cell disease , 2008, British journal of haematology.
[9] John N Weinstein,et al. Chromatin challenges during DNA replication: a systems representation. , 2008, Molecular biology of the cell.
[10] H. Leonhardt,et al. Dynamics of Dnmt1 interaction with the replication machinery and its role in postreplicative maintenance of DNA methylation , 2007, Nucleic acids research.
[11] N. Mahmud,et al. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents. , 2007, Experimental Hematology.
[12] K. Ghoshal,et al. 5-Aza-Deoxycytidine Induces Selective Degradation of DNA Methyltransferase 1 by a Proteasomal Pathway That Requires the KEN Box, Bromo-Adjacent Homology Domain, and Nuclear Localization Signal , 2005, Molecular and Cellular Biology.
[13] S. Boehrer,et al. Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. , 2005, Cancer research.
[14] Clara Nervi,et al. Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. , 2005, Cancer research.
[15] F. Yamasaki,et al. 5‐azacytidine supports the long‐term repopulating activity of cord blood CD34+ cells , 2004, American journal of hematology.
[16] Lesley J. Murray,et al. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal. , 2004, Cytotherapy.
[17] N. Mahmud,et al. Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A. , 2004, Blood.
[18] D. Skalnik,et al. Histone deacetylase activity is required for embryonic stem cell differentiation , 2004, Genesis.
[19] J. Desimone. Approaches to the reactivation of hemoglobin F as a treatment for sickle cell disease. , 2004, Clinical advances in hematology & oncology : H&O.
[20] R. Hoffman,et al. Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease. , 2003, Blood.
[21] John Anastasi,et al. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. , 2002, Immunity.
[22] Y. Hayashi,et al. Sensitization by 5‐aza‐2′‐deoxycytidine of leukaemia cells with MLL abnormalities to induction of differentiation by all‐trans retinoic acid and 1α,25‐dihydroxyvitamin D3 , 2001, British journal of haematology.
[23] T. Naoe,et al. Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy , 1999, Leukemia.
[24] Y. Saunthararajah,et al. Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells. , 1999, Cancer research.
[25] U. Thorsteinsdóttir,et al. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. , 1995, Genes & development.
[26] T. Haaf,et al. The effects of 5-azacytidine and 5-azadeoxycytidine on chromosome structure and function: implications for methylation-associated cellular processes. , 1995, Pharmacology & therapeutics.
[27] K. Kohn,et al. Differences in DNA damage produced by incorporation of 5-aza-2'-deoxycytidine or 5,6-dihydro-5-azacytidine into DNA of mammalian cells. , 1986, Cancer research.
[28] A. Riggs,et al. Purification of human DNA (cytosine‐5‐)‐methyltransferase , 1985, Journal of cellular biochemistry.
[29] A. Fusco,et al. 5-Aza-2'-deoxycytidine induces terminal differentiation of leukemic blasts from patients with acute myeloid leukemias. , 1984, Blood.
[30] J. Christman,et al. Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2'-deoxycytidine. , 1982, The Journal of biological chemistry.
[31] Peter A. Jones,et al. Cellular differentiation, cytidine analogs and DNA methylation , 1980, Cell.